# Anti-infection of Low-does IL-2 in SLE

> **NCT02932137** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 30 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT02932137
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-05
- **Primary completion:** 2016-12-16
- **Final completion:** 2017-08-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02932137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02932137, "Anti-infection of Low-does IL-2 in SLE". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02932137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*